Grossâmargin trend:
In the Q2â2025 release Hyperfine disclosed that the SwoopÂź systemâs gross margin has continued to improve, moving from roughly 38âŻ% in the prior quarter to about 42âŻ% on a GAAP basis for the period. The upside reflects a higher proportion of recurring service and softwareâlicense revenue (which carries a markedly higher margin than the hardware component) and a modest lift in unitâsales volume that is now spread over a larger, more efficient production base.
Costâstructure changes:
Two key adjustments underpin the margin expansion:
Manufacturingâcost compression â The company has renegotiated key component contracts and shifted a portion of the hardware assembly to a lowerâcost, domestic contractâmanufacturer. Unitâcosts for the magnet and gradient coil subsystems are down 5â7âŻ% versus Q1â2025, while the billâofâmaterials for the AIâprocessing board has been reduced through a new siliconâpartner partnership.
Shift to a âsoftwareâfirstâ revenue mix â Hyperfine now books a larger share of its recurring AIâsoftware subscription fees and remoteâmonitoring services upâfront, which are recognized as grossâmarginâfriendly recurring revenue. This reâbalancing reduces the weight of lowâmargin hardware sales in the overall cost base and cushions the impact of any residual componentâprice volatility.
Trading implications:
The strengthening gross margin and the ongoing costâstructure rationalization signal a more resilient and scalable business model for the SwoopÂź platform. Assuming the margin trajectory holds, the incremental upside from serviceârelated cash flow should support a higher forwardâPE multiple relative to peers in the medicalâdevice space. For traders, the data point removes a nearâterm downside catalyst and opens the door for shortâterm bullish positioningâeither via a direct long on HYPR or by taking a long exposure to the broader AIâenabled imaging themeâwhile still keeping a watch on inventoryâbuild dynamics and any macroâdriven capâex slowâdowns that could temper hardware demand.